Nomegestrol acetate Report issue

Small molecule Experimental
AACT ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Nomegestrol acetate (NOMAC), sold under the brand names Lutenyl and Zoely among others, is a progestin medication which is used in birth control pills, menopausal hormone therapy, and for the treatment of gynecological disorders. It is available both alone and in combination with an estrogen. NOMAC is taken by mouth. A birth control implant for placement under the skin was also developed but ultimately was not marketed.   Wikipedia

Chemistry

  • SMILES: CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(=O)C
  • InChIKey: IIVBFTNIGYRNQY-YQLZSBIMSA-N
  • Mol. Mass: 370.49
  • ALogP: 4.19
  • ChEMBL Molecules:
    nomegestrol acetate  
    nomegestrol  
More Chemistry

Pharmacology

Alternative names

19-norpregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl- | lutenyl | nomegestrol | nomegestrol acetate | org-10486-0 | tx 066 | tx-066

Organizations (8)

Research & Development (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (1)


 

Contraception

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Contraception (Phase 4)

Dysmenorrhea (Phase 2)

Healthy Volunteers (Phase 1)

Menorrhagia (Phase 4)

Multiple Sclerosis (Phase 3)

Ovulation Inhibition (Phase 4)

Therapeutic Equivalency (Phase 1)

Thrombophilia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial Organizations: 8

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue